Inhibition of P-Selectin and PSGL-1 using humanized monoclonal antibodies increases the sensitivity of multiple myeloma cells to bortezomib

Barbara Muz, Washington University School of Medicine in St. Louis
Feda Azab, Washington University School of Medicine in St. Louis
Pilar de la Puente, Washington University School of Medicine in St. Louis
Scott Rollins, Selexys Pharmaceuticals in St. Louis
Richard Alvarez, Selexys Pharmaceuticals
Ziad Kawar, Selexys Pharmaceuticals
Abdel Kareem Azab, Washington University School of Medicine in St. Louis

Abstract